Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,160.31 +12.39 0.58%
FTSE 100 5,391.14 +34.80 0.65%
DAX 6,396.84 +73.65 1.16%
Ticker Volume Price Price Delta
Nikkei 8,657.08 +63.93 0.74%
TOPIX 727.03 +5.92 0.82%
Hang Seng 19,055.50 +254.47 1.35%
Gold 1,556.80 -0.92%
EUR-USD 1.2490 -0.1010%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,391.14 +0.65%
STOXX 50 2,160.31 +0.58%
DAX 6,396.84 +1.16%
Oil (WTI) 90.76 -0.11%
U.S. 10-year 1.745% +0.007
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Exchange: Copenhagen
  • Sector: Consumer, Non-cyclical
  • Industry: Food
  • Sub-Industry: Food-Misc/Diversified

Chr Hansen Holding A/S

Add to Portfolio

CHR:DC

167.500 DKK 0.500 0.30%

As of 11:04:51 ET on 05/29/2012.

Snapshot for Chr Hansen Holding A/S (CHR)

Open: 168.000 Day's Range: 165.900 - 168.000 Volume: 419,391 Bid: 167.500
Previous Close: 168.000 52wk Range: 102.700 - 168.000 1-Yr Rtn: +38.98% Ask: 167.600

Stock Chart for CHR

No chart data available.
  • CHR:DC 167.500
  • 1D
  • 1M
  • 1Y
168.000
Interactive CHR Chart

Previous Close

Key Statistics for CHR

Current P/E Ratio (ttm) 27.1566
Estimated P/E (08/2012) 24.1864
Earnings Per Share (EUR) (ttm) 0.8300
Est. EPS (EUR) (08/2012) 0.9320
Est. PEG Ratio 1.0994
Market Cap (M DKK) 23,120.73
Shares Outstanding (M) 138.03
Enterprise Value (M EUR) (ttm) 3,525.79
Enterprise Value/EBITDA (ttm) -
Price/Book (mrq) 4.7550
Price/Sale (ttm) 4.8950
Dividend Indicated Gross Yield 2.1313
Next Earnings Announcement 07/04/2012
More CHR Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for CHR

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)
More CHR Income Statement Data
  • Total Assets
  • Total Liabilities (M/EUR)
  • Debt to Assets (%)
More CHR Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/EUR)
More CHR Cash Flow Data

Company Profile & Key Executives for CHR

Chr. Hansen Holding A/S develops and produces natural food ingredients, pharmaceuticals, and biotechnological products. The Company's product line includes dairy enzymes, cultures, natural colors, and flavor solutions, as well as products for the diagnosis, prevention, relief, and cure of allergies. Christian Hansen sells worldwide for the human, animal, and industrial markets.

Ole AndersenChairmanFrederic SteveninVice Chairman
Lars Vinge FrederiksenPresident/CEOKlaus PedersenCFO/Member-Exec Board
More Company Profile & Key Executives for CHR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements